Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

NCT01431196 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Stage II Breast Cancer
Stage III Breast Cancer

Interventions

BIOLOGICAL: Autologous dendritic cell vaccination

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Collaborators

[object Object]
[object Object]